Detail akcie HK Pharma Dig Rg online

Business Summary: Hong Kong Pharma Digital Technology Holdings Ltd is an investment holding company mainly engaged in the over the counter (OTC) pharmaceutical business. The Company mainly provides two services. The supply chain services mainly provide OTC pharmaceutical cross-border e-commerce supply chain services. The procurement and distribution services mainly provide OTC pharmaceutical cross-border procurement and distribution services.
Financial Summary: BRIEF: For the fiscal year ended 31 March 2025, Cellyan Biotechnology Co Ltd revenues increased 22% to $20.3M. Net loss totaled $27K vs. income of $1.3M. Revenues reflect Supply chain services segment increase of 23% to $12.5M, Procurement and distribution segment increase of 21% to $7.5M. Net loss reflects Hong Kong segment income decrease of 92% to $132K.